Articles by Rob Dillard
Age has no significant impact on the prognosis of elderly patients with HCC following hepatectomy.
A novel signature can assess necroptosis-related genes to predict the prognosis of patients with hepatocellular carcinoma.
A prediction model may serve as a viable management tool for patients with hepatocellular carcinoma undergoing TACE.
A study assessed the safety and efficacy of third-line treatment regimens for metastatic colorectal cancer.
Underwater endoscopic mucosal resection is a viable and effective method for removing colorectal lesions.
A study compared the association of tumor response evaluated by MRI, CT, and ultrasound in patients with HCC.
Tislelizumab may represent a potential first-line therapy for patients with uHCC.
A study established a risk prediction model of ocular metastasis in patients with primary liver cancer.
Histotripsy is an innovative modality for treating liver tumors that offers several advantages.
The number of arteries treated during transarterial chemoembolization did not affect outcomes in liver cancer patients.
Radiation lobectomy with transarterial embolization of Yttrium-90 is a viable option for hepatocellular carcinoma.
Durvalumab plus tremelimumab significantly improved overall survival in patients with unresectable liver cancer.
The combination of pembrolizumab and lenvatinib did not improve survival in metastatic CRC.
The FRESCO-2 study showed that fruquintinib resulted in an overall survival benefit in metastatic colorectal cancer.
Dr. Eng discusses the phase 3 FRESCO-2 study and how fruquintinib fits in with current treatments for advanced CRC.
The rate of colorectal cancer (CRC) screenings decreased by more than 20% during the COVID-19 pandemic.
Results from a recent study suggest a novel therapy that may effectively treat pancreatic ductal adenocarcinoma.
Researchers identified a circRNA signature as a potential biomarker for GEP-NETs.
Patients with advanced stage gastroenteropancreatic neuroendocrine tumors appear to benefit from PRRT.
Researchers assessed whether the aggressive warming of core body temperature reduces complications in esophageal cancer.
630 Madison Ave.
Manalapan, NJ 07726
About Column
Contribute Column
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.